Aptamer Group plc, a developer of synthetic oligonucleotide-based binding reagents for life sciences applications, and ...

The York-based Aptamer Group says it ends 2025 with strong momentum as global pharma partnerships drive confidence for 2026.

York-based biotech firm Aptamer Group has announced a licensing agreement with synthetic biology and genomics company Twist ...

YARTEMLEA is approved by the U.S. FDA for the treatment of TA-TMA in adults and in children ages two years and older. A marketing authorization application for YARTEMLEA for TA-TMA is under review by ...

Aptamer Group Plc ( (GB:APTA) ) has provided an update.

Candidates preparing for JEE Advanced 2026 can download the official syllabus PDF from jeeadv.ac.in, released by IIT Roorkee.

Researchers have captured real-time "molecular movies" showing how an enzyme changes shape during catalysis. The study was ...

A research team at Leibniz-HKI has described a new enzyme that renders the highly toxic molecule malleicyprol harmless.

Researchers discovered that a tiny structural feature of the enzyme GPX4 helps keep neurons safe. A rare mutation removes this protection, allowing harmful molecules to damage cell membranes and ...

Scientists have identified a small flaw in the enzyme GPX4 that prevents neurons from defending themselves. This mutation, ...

Alcohol consumption leads to the formation of a toxic compound called acetaldehyde, which damages DNA. A research team from ...